These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 27493131

  • 1. The Platin-X series: activation, targeting, and delivery.
    Basu U, Banik B, Wen R, Pathak RK, Dhar S.
    Dalton Trans; 2016 Aug 16; 45(33):12992-3004. PubMed ID: 27493131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
    Najjar A, Rajabi N, Karaman R.
    Curr Pharm Des; 2017 Aug 16; 23(16):2366-2376. PubMed ID: 28155621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression.
    Jin S, Guo Y, Song D, Zhu Z, Zhang Z, Sun Y, Yang T, Guo Z, Wang X.
    Inorg Chem; 2019 May 06; 58(9):6507-6516. PubMed ID: 31013065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multi-action Pt(IV) anticancer agents; do we understand how they work?
    Gibson D.
    J Inorg Biochem; 2019 Feb 06; 191():77-84. PubMed ID: 30471522
    [Abstract] [Full Text] [Related]

  • 11. Monofunctional and higher-valent platinum anticancer agents.
    Johnstone TC, Wilson JJ, Lippard SJ.
    Inorg Chem; 2013 Nov 04; 52(21):12234-49. PubMed ID: 23738524
    [Abstract] [Full Text] [Related]

  • 12. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery.
    Ma J, Wang Q, Huang Z, Yang X, Nie Q, Hao W, Wang PG, Wang X.
    J Med Chem; 2017 Jul 13; 60(13):5736-5748. PubMed ID: 28603992
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs.
    Medrano MÁ, Álvarez-Valdés A, Perles J, Lloret-Fillol J, Muñoz-Galván S, Carnero A, Navarro-Ranninger C, Quiroga AG.
    Chem Commun (Camb); 2013 May 25; 49(42):4806-8. PubMed ID: 23591566
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug.
    Ravera M, Gabano E, Bonzani D, Zanellato I, Arrais A, Cantamessa S, Biggiogera M, Osella D.
    J Inorg Biochem; 2018 Dec 25; 189():185-191. PubMed ID: 30312905
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
    Gao C, Zhang Y, Chen J, Wang T, Qian Y, Yang B, Dong P, Zhang Y.
    Mini Rev Med Chem; 2016 Dec 25; 16(11):872-91. PubMed ID: 26586124
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z, Wang H, Li Y, Qin Y, Xu L, Bowers DJ, Gangoda M, Li X, Yang HB, Zheng YR.
    Chem Commun (Camb); 2018 Jan 18; 54(7):731-734. PubMed ID: 29303526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.